When was ARUNITA UK LTD founded?

ARUNITA UK LTD was officially incorporated on 14 July 2026 under company number 17339433.

What is the current status of ARUNITA UK LTD?

ARUNITA UK LTD's current status is Active.

What does ARUNITA UK LTD do?

ARUNITA UK LTD operates in: 46460 - Wholesale of pharmaceutical goods, 47190 - Other retail sale in non-specialised stores, 47749 - Retail sale of medical and orthopaedic goods in specialised stores (not incl. hearing aids) n.e.c., 86900 - Other human health activities.

What is ARUNITA UK LTD's registered address?

14 The Avenue, March, Cambridgeshire, United Kingdom, PE15 9PR

ARUNITA UK LTD

Company Number: 17339433

Company Type: Private Limited Company
Status: Active
Incorporated: 14 July 2026

Nature of Business (SIC Codes)

Accounts

Accounting Reference Date: 31 July
Last Accounts Made Up To: —
Next Accounts Due: 14 April 2028

Confirmation Statement

Last Statement: 1 September 2026
Next Due: 15 September 2027

Previous Names

NUTRIGEN UK LTD2 September 2026

FAQs

Frequently Asked Questions

Detailed answers about ARUNITA UK LTD, including incorporation, status, business activity, and accounts information.

When was ARUNITA UK LTD founded?: ARUNITA UK LTD was officially incorporated on 14 July 2026 and is registered under company number 17339433. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is ARUNITA UK LTD?: Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of ARUNITA UK LTD?: ARUNITA UK LTD's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.